CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) has risen more than 35% over the last month. TWMJF stock continues to trade in an uptrend and legalization of marijuana for recreational use in Canada is a milestone that is expected to enhance the company’s growth prospects even further.
Strong organic growth on the medical cannabis side of the business has been a key driver of the TWMJF’s bottom line. However, it is the recreational side of the business which could generate more sales for the company. This month, Valens GroWorks Corp, the parent company of Valens Agritech Ltd., announced that it signed a supply and sales agreement with TWMJF. This means that Valens’ products will be added to TWMJF’s CraftGrow distribution network. Context here is that CraftGrow is a distribution program that is designed to accelerate speed to market for newly licensed cannabis producers. “We welcome Valens to the Canopy Growth family and look forward to collaborating with their team to provide a steady and high-quality source of cannabis products to increase product variety for our customers.”
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is one of the bigger growers. The company produces and sells medical marijuana in Canada. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. It also sells its products through online.
Find out when $TWMJF stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
According to company materials, “Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.”
Also from their materials, “Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.”
Also important to note, TWMJF is set to expand its footprint on the international scene as it is one of just a handful of Canadian growers that are authorized to export dried cannabis to foreign countries. Germany has already emerged as a target market as it lacks the domestic production to accommodate patients.
Currently trading at a market capitalization of $1.76B, Canopy Growth has a significant war chest ($116M) of cash on the books. TWMJF is pulling in trailing 12-month revenues of $48.8M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 127.3%. Sign-up for continuing coverage on shares of $TWMJF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: We hold no position in $TWMJF, either long or short, and we have not been compensated for this article.